ALZN:Com New July 2024/Alzamend Neuro Inc - Stock Price Quote and Dividend Data
ALZN STOCK PRICE LATEST CLOSE
$0.80
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Com New July 2024/Alzamend Neuro Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Com New July 2024/Alzamend Neuro Inc Stock Price Information
52-Week Low/High Stock Price$0.64 - $15.06
Percent Held by Institutions-2.95%
Revenue$0
Net Income$-5,266,371
Cash Flow$-8,729,826
EPS-0.19%
Market Cap$5,458,470
PE Ratio to Industry123%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-91.30%
Total Return Last 3 Years-99.53%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 09, 2025
Com New July 2024/Alzamend Neuro Inc Annual Stock Dividends
No Data available for Payment History.
Com New July 2024/Alzamend Neuro Inc Dividend Payment History
| No dividends retrieved for ALZN |
Com New July 2024/Alzamend Neuro Inc Other Dividend Details
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). Co.'s pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 01, 2025ALZN STOCK PRICE DECREASE: Com New July 2024/Alzamend Neuro Inc on 04-01-2025 decreased stock price > 10% from $1.06 to $0.95
Mar. 28, 2025ALZN STOCK PRICE INCREASE: Com New July 2024/Alzamend Neuro Inc on 03-28-2025 increased stock price > 10% from $1.00 to $1.10
Mar. 18, 2025ALZN STOCK PRICE INCREASE: Com New July 2024/Alzamend Neuro Inc on 03-18-2025 increased stock price > 10% from $0.68 to $0.89
Dec. 21, 2024ALZN STOCK PRICE DECREASE: Com New July 2024/Alzamend Neuro Inc on 12-21-2024 decreased stock price > 10% from $1.25 to $1.11
Nov. 07, 2024ALZN STOCK PRICE DECREASE: Com New July 2024/Alzamend Neuro Inc on 11-07-2024 decreased stock price > 10% from $1.64 to $1.45
Aug. 28, 2024ALZN STOCK PRICE DECREASE: Alzamend Neuro Inc on 08-28-2024 decreased stock price > 10% from $2.85 to $2.54
Aug. 23, 2024ALZN STOCK PRICE DECREASE: Alzamend Neuro Inc on 08-23-2024 decreased stock price > 10% from $4.35 to $3.39
Aug. 21, 2024ALZN STOCK PRICE DECREASE: Alzamend Neuro Inc on 08-21-2024 decreased stock price > 10% from $5.85 to $4.39
Aug. 20, 2024ALZN STOCK PRICE INCREASE: Alzamend Neuro Inc on 08-20-2024 increased stock price > 10% from $2.04 to $5.85
Aug. 06, 2024ALZN STOCK PRICE DECREASE: Alzamend Neuro Inc on 08-06-2024 decreased stock price > 10% from $3.26 to $2.54
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
